Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Extended Vs Standard Pelvic Lymphadenectomy During Laparoscopic Radical Prostatectomy For Intermediate‐ And High‐risk Prostate Cancer

C. Eden, A. Arora, P. Rouse
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Study Type – Therapy (case series)
Level of Evidence 4
This paper references
10.1016/J.EURURO.2007.07.035
The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.
A. Mattei (2008)
10.1001/JAMA.1997.03540420041027
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
A. Partin (1997)
10.1016/S0022-5347(17)56906-2
Extended pelvic lymphadenectomy for prostatic cancer.
M. Golimbu (1979)
10.1016/j.eururo.2009.03.012
Pelvic lymph node dissection in prostate cancer.
A. Briganti (2009)
Extended pelvic lymphadenectomy for prostatic cancer.
J. Kaswick (1980)
10.3109/9780203091432-13
Anatomic radical retropubic prostatectomy
J. Parsons (2005)
10.1016/S0022-5347(05)65177-4
Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
A. Heidenreich (2002)
10.1016/S0022-5347(05)64055-4
Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer.
Travis Clark (2003)
10.1201/b14450-78
Anatomic radical retropubic prostatectomy
Mao Qi-qi (2010)
10.1002/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO;2-P
Risk of prostate carcinoma death in patients with lymph node metastasis
L. Cheng (2001)
10.1097/01.JU.0000049032.38743.C7
Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
P. Bader (2003)
Randomised prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer
T Clark (2003)
10.1002/(SICI)1097-0142(20000501)88:9<2105::AID-CNCR16>3.0.CO;2-3
The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma
E. Crawford (2000)
10.1016/J.JURO.2007.09.027
The role of pelvic lymphadenectomy for prostate cancer--therapeutic?
M. Wagner (2008)
10.1016/J.EURURO.2007.04.020
Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
A. Heidenreich (2007)
10.1016/J.EURURO.2006.01.043
Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.
A. Briganti (2006)
Extended pelvic lymphadenectomy in men undergoing radical retropubic prostatectomy – data on > 300 cases
F Wawroschek (2005)
10.1016/j.juro.2007.10.072
Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006.
M. Musch (2008)
10.1016/j.eururo.2009.09.003
Re: Alberto Briganti, Michael L. Blute, James H. Eastham, et al. Pelvic lymph node dissection in prostate cancer. Eur urol 2009;55:1251-65.
J. Alcover (2009)
10.1016/S0022-5347(05)00685-3
The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.
T. Masterson (2006)
10.1016/j.eururo.2008.05.018
Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
A. Briganti (2008)
10.1016/S0022-5347(01)65406-5
Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic.
K. Weingärtner (1996)
The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate cancer
ED Crawford (2000)
10.1016/J.JURO.2007.05.048
Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
S. Boorjian (2007)
10.1097/01.JU.0000143448.04161.CC
Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
S. Daneshmand (2004)
10.1097/01.JU.0000140912.45821.1D
Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer.
M. Allaf (2004)
10.1016/J.EURURO.2006.08.015
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer.
A. Briganti (2006)
10.1097/01.JU.0000144640.26182.41
Transperitoneal or extraperitoneal laparoscopic radical prostatectomy: does the approach matter?
C. Eden (2004)
10.1016/J.JURO.2007.03.018
Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.
K. Touijer (2007)
10.1159/000070140
Prostate Lymphoscintigraphy and Radio-Guided Surgery for Sentinel Lymph Node Identification in Prostate Cancer
F. Wawroschek (2003)
10.1016/S1470-2045(06)70700-8
Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.
E. Messing (2006)
10.1016/J.JURO.2006.10.043
Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.
J. Stein (2007)
10.1016/S0022-5347(01)61700-2
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
A. D'Amico (1998)
10.1016/S0090-4295(00)01039-6
Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer.
J. Batuello (2001)
10.1016/S1569-9056(06)60620-9
NUMBER OF SENTINEL LYMPH NODES (SLN) OF THE PROSTATE LOCALISED OUTSIDE THE AREAS OF “LIMITED” VERSUS “EXTENDED” PELVIC NODE DISSECTION
A. Mattei (2006)
10.1016/j.eururo.2008.12.006
Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases.
Antje Feicke (2009)
10.1016/S0022-5347(05)64670-8
Is a limited lymph node dissection an adequate staging procedure for prostate cancer?
P. Bader (2002)
Complications of pelvic
M Musch (2003)



This paper is referenced by
10.1111/bju.13993
More extended lymph node dissection template at radical prostatectomy detects metastases in the common iliac region and in the fossa of Marcille
Lydia Maderthaner (2018)
10.4293/108680813X13794522666365
Posterior Reconstruction and Outcomes of Laparoscopic Radical Prostatectomy in a High-Risk Setting
U. Anceschi* (2013)
10.23736/S0393-2249.17.02838-7
Extended versus standard pelvic lymphadenectomy during robot-assisted radical prostatectomy: the role of extended template as an independent predictor of lymph node invasion with comparable morbidity burden.
F. Mistretta (2017)
10.1016/j.purol.2013.07.018
[Comparison of the morbidity between limited and extended pelvic lymphadenectomy during laparoscopic radical prostatectomy].
B. Rousseau (2014)
10.1111/j.1464-410X.2010.10016.x
The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate‐ and high‐risk prostate cancer
R. Schiavina (2011)
10.1136/jclinpath-2016-203643
Lymph node staging in prostate cancer: perspective for the pathologist
S. Prendeville (2016)
10.1016/J.PUROL.2013.07.018
Comparaison de la morbidité entre curage étendu et curage limité au cours de la prostatectomie radicale laparoscopique
B. Rousseau (2014)
10.1016/j.ucl.2011.07.003
Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery.
A. Hakimi (2011)
10.1111/j.1464-410X.2010.09395_1.x
IS IT TIME TO RE‐DESIGN THE HAEMATURIA CLINIC?
R. Bryan (2010)
10.1089/end.2011.0209
Comparison of extraperitoneal and transperitoneal pelvic lymph node dissection during minimally invasive radical prostatectomy.
J. K. Mullins (2011)
10.1016/j.urology.2011.05.021
Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification.
G. Ploussard (2011)
10.1016/j.eururo.2016.12.003
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
N. Fossati (2017)
10.1002/prm2.12005
Whether extended pelvic lymph node dissection should be performed in prostate cancer: The present evidence from a systematic review and meta‐analysis
Y. Zheng (2020)
ASSOCIATION OF OVERACTIVE BLADDER AND C-REACTIVE PROTEIN LEVELS: RESULTS FROM THE BOSTON AREA COMMUNITY HEALTH (BACH) SURVEY
Ortiz Rm (2012)
10.1111/j.1464-410X.2012.10976_5.x
INCIDENCE OF LYMPHOCELES AFTER ROBOT‐ASSISTED PELVIC LYMPH NODE DISSECTION
C. Eden (2012)
10.1007/978-3-319-32641-2_14
Pelvic Lymph Node Dissection: Open Benchmarks with Lymphoscintigraphy
D. Nguyen (2016)
10.1111/j.1464-410X.2010.09965_1.x
[18F]‐FLUOROCHOLINE POSITRON‐EMISSION/COMPUTED TOMOGRAPHY FOR LYMPH NODE STAGING OF PATIENTS WITH PROSTATE CANCER: PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
P. Dundee (2011)
10.1007/s10147-017-1223-x
Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan
S. Morizane (2017)
10.1080/07357907.2019.1675076
Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution
Ikko Tomisaki (2019)
10.1016/j.eururo.2013.03.057
Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.
G. Ploussard (2014)
10.3389/fsurg.2018.00052
Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection
M. Roscigno (2018)
10.1007/s00432-013-1574-2
A systematic review and meta-analysis of comparative studies on the efficacy of extended pelvic lymph node dissection in patients with clinically localized prostatic carcinoma
L. Gao (2013)
10.1007/s00345-013-1056-9
Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy
M. Liss (2013)
10.1089/end.2010.0451
Cancer control, continence, and potency after laparoscopic radical prostatectomy beyond the learning and discovery curves.
C. Eden (2011)
10.1111/j.1464-410X.2010.09395_3.x
THE NUMBER OF NEGATIVE PELVIC LYMPH NODES REMOVED DOES NOT AFFECT THE RISK OF BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY
C. Eden (2010)
10.1245/s10434-010-1223-9
In Reply: Continuing Discussion Regarding Novel Technique for Inguinal Lymphadenectomy
K. Delman (2010)
10.1111/J.1464-410X.2012.10976_4.X
REPLY. ARE WE PRODUCING COMPETENT AND TECHNOLOGY‐ATTENTIVE UROLOGISTS?
K. Ahmed (2012)
10.1111/j.1464-410X.2012.11765.x
Extended vs standard lymph node dissection in robot‐assisted radical prostatectomy for intermediate‐ or high‐risk prostate cancer: a propensity‐score‐matching analysis
K. Kim (2013)
10.1111/j.1464-410X.2009.08707.x
The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy
A. Murphy (2010)
10.1159/000500330
Lymph Nodes Invasion of Marcille’s Fossa Associates with High Metastatic Load in Prostate Cancer Patients Undergoing Extended Pelvic Lymph Node Dissection: The Role of “Marcillectomy”
A. Porcaro (2019)
10.1016/s1569-9056(18)32049-9
The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: A systematic review
N. Fossati (2018)
10.1097/MOU.0b013e32835af286
Comparative effectiveness of minimally invasive versus open lymphadenectomy in urological cancers
S. Prasad (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar